Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
28015 | 216 | 44.9 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
553 | 2 | EMBRYONIC STEM CELLS//HUMAN EMBRYONIC STEM CELLS//INDUCED PLURIPOTENT STEM CELLS | 14582 |
28015 | 1 | STEM CELLS REPROD ENGN//HEART DIS CARDIOTHORAC SURG//ACQUIRED IMMUNE PRIVILEGE | 216 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | STEM CELLS REPROD ENGN | address | 476176 | 4% | 42% | 8 |
2 | HEART DIS CARDIOTHORAC SURG | address | 212048 | 1% | 50% | 3 |
3 | ACQUIRED IMMUNE PRIVILEGE | authKW | 141368 | 0% | 100% | 1 |
4 | ADULT STEMS CELLS | authKW | 141368 | 0% | 100% | 1 |
5 | ANTIGEN PROCESSING CHAPERONES | authKW | 141368 | 0% | 100% | 1 |
6 | ANTITUMOR FACTORS | authKW | 141368 | 0% | 100% | 1 |
7 | APM COMPONENTS | authKW | 141368 | 0% | 100% | 1 |
8 | BETA2 MICROGLOBULIN GENE TARGETING STRATEGY | authKW | 141368 | 0% | 100% | 1 |
9 | BLOOD GROUP ABO SYSTEM | authKW | 141368 | 0% | 100% | 1 |
10 | BLOOD PHARMING | authKW | 141368 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell & Tissue Engineering | 19304 | 28% | 0% | 60 |
2 | Immunology | 808 | 30% | 0% | 65 |
3 | Cell Biology | 806 | 32% | 0% | 69 |
4 | Hematology | 716 | 18% | 0% | 39 |
5 | Transplantation | 585 | 11% | 0% | 24 |
6 | Medicine, Research & Experimental | 391 | 17% | 0% | 36 |
7 | Biotechnology & Applied Microbiology | 350 | 18% | 0% | 39 |
8 | Oncology | 181 | 17% | 0% | 36 |
9 | Multidisciplinary Sciences | 180 | 5% | 0% | 11 |
10 | Pathology | 78 | 6% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STEM CELLS REPROD ENGN | 476176 | 4% | 42% | 8 |
2 | HEART DIS CARDIOTHORAC SURG | 212048 | 1% | 50% | 3 |
3 | CARDIOVASC REGENERAT MED SURG SCIENTIST | 141368 | 0% | 100% | 1 |
4 | HLA MED JEAN DAUSSET NETWORK TRANSPLANTEX | 141368 | 0% | 100% | 1 |
5 | IMMUNOLIFR ALFRED JOSTEA 1833 | 141368 | 0% | 100% | 1 |
6 | INS MOL EMBRYOL GENET | 141368 | 0% | 100% | 1 |
7 | MEDINSERMU633 CARDIOL | 141368 | 0% | 100% | 1 |
8 | MSTP PROGRAMS | 141368 | 0% | 100% | 1 |
9 | NIH BIOMED EXCELLENCE COBRE TISSUE REPAIR | 141368 | 0% | 100% | 1 |
10 | REGENERAT PROTECT THER IES | 141368 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STEM CELLS | 14514 | 10% | 0% | 21 |
2 | STEM CELL RESEARCH | 10781 | 4% | 1% | 8 |
3 | SEMINARS IN IMMUNOPATHOLOGY | 10438 | 3% | 1% | 6 |
4 | STEM CELLS AND DEVELOPMENT | 6286 | 5% | 0% | 10 |
5 | REGENERATIVE MEDICINE | 5822 | 2% | 1% | 5 |
6 | STEM CELL REVIEWS AND REPORTS | 5822 | 2% | 1% | 5 |
7 | STEM CELL REVIEWS | 3896 | 1% | 1% | 2 |
8 | CELL STEM CELL | 2243 | 2% | 0% | 4 |
9 | CURRENT STEM CELL RESEARCH & THERAPY | 1272 | 1% | 0% | 2 |
10 | CANCER IMMUNOLOGY RESEARCH | 1255 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACQUIRED IMMUNE PRIVILEGE | 141368 | 0% | 100% | 1 | Search ACQUIRED+IMMUNE+PRIVILEGE | Search ACQUIRED+IMMUNE+PRIVILEGE |
2 | ADULT STEMS CELLS | 141368 | 0% | 100% | 1 | Search ADULT+STEMS+CELLS | Search ADULT+STEMS+CELLS |
3 | ANTIGEN PROCESSING CHAPERONES | 141368 | 0% | 100% | 1 | Search ANTIGEN+PROCESSING+CHAPERONES | Search ANTIGEN+PROCESSING+CHAPERONES |
4 | ANTITUMOR FACTORS | 141368 | 0% | 100% | 1 | Search ANTITUMOR+FACTORS | Search ANTITUMOR+FACTORS |
5 | APM COMPONENTS | 141368 | 0% | 100% | 1 | Search APM+COMPONENTS | Search APM+COMPONENTS |
6 | BETA2 MICROGLOBULIN GENE TARGETING STRATEGY | 141368 | 0% | 100% | 1 | Search BETA2+MICROGLOBULIN+GENE+TARGETING+STRATEGY | Search BETA2+MICROGLOBULIN+GENE+TARGETING+STRATEGY |
7 | BLOOD GROUP ABO SYSTEM | 141368 | 0% | 100% | 1 | Search BLOOD+GROUP+ABO+SYSTEM | Search BLOOD+GROUP+ABO+SYSTEM |
8 | BLOOD PHARMING | 141368 | 0% | 100% | 1 | Search BLOOD+PHARMING | Search BLOOD+PHARMING |
9 | CARDIAC TISSUE CONSTRUCTS | 141368 | 0% | 100% | 1 | Search CARDIAC+TISSUE+CONSTRUCTS | Search CARDIAC+TISSUE+CONSTRUCTS |
10 | CLINIC PATHOLOGIC | 141368 | 0% | 100% | 1 | Search CLINIC+PATHOLOGIC | Search CLINIC+PATHOLOGIC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ENGLISH, K , WOOD, KJ , (2011) IMMUNOGENICITY OF EMBRYONIC STEM CELL-DERIVED PROGENITORS AFTER TRANSPLANTATION.CURRENT OPINION IN ORGAN TRANSPLANTATION. VOL. 16. ISSUE 1. P. 90-95 | 21 | 51% | 16 |
2 | KRUSE, V , HAMANN, C , MONECKE, S , CYGANEK, L , ELSNER, L , HUBSCHER, D , WALTER, L , STRECKFUSS-BOMEKE, K , GUAN, K , DRESSEL, R , (2015) HUMAN INDUCED PLURIPOTENT STEM CELLS ARE TARGETS FOR ALLOGENEIC AND AUTOLOGOUS NATURAL KILLER (NK) CELLS AND KILLING IS PARTLY MEDIATED BY THE ACTIVATING NK RECEPTOR DNAM-1.PLOS ONE. VOL. 10. ISSUE 5. P. - | 22 | 43% | 3 |
3 | TANG, C , DRUKKER, M , (2011) POTENTIAL BARRIERS TO THERAPEUTICS UTILIZING PLURIPOTENT CELL DERIVATIVES: INTRINSIC IMMUNOGENICITY OF IN VITRO MAINTAINED AND MATURED POPULATIONS.SEMINARS IN IMMUNOPATHOLOGY. VOL. 33. ISSUE 6. P. 563-572 | 28 | 33% | 18 |
4 | ZHANG, R , LIU, TY , SENJU, S , HARUTA, M , HIROSAWA, N , SUZUKI, M , TATSUMI, M , UEDA, N , MAKI, H , NAKATSUKA, R , ET AL (2015) GENERATION OF MOUSE PLURIPOTENT STEM CELL-DERIVED PROLIFERATING MYELOID CELLS AS AN UNLIMITED SOURCE OF FUNCTIONAL ANTIGEN-PRESENTING CELLS.CANCER IMMUNOLOGY RESEARCH. VOL. 3. ISSUE 6. P. 668 -677 | 19 | 41% | 3 |
5 | SENJU, S , HIRATA, S , MOTOMURA, Y , FUKUMA, D , MATSUNAGA, Y , FUKUSHIMA, S , MATSUYOSHI, H , NISHIMURA, Y , (2010) PLURIPOTENT STEM CELLS AS SOURCE OF DENDRITIC CELLS FOR IMMUNE THERAPY.INTERNATIONAL JOURNAL OF HEMATOLOGY. VOL. 91. ISSUE 3. P. 392-400 | 15 | 58% | 12 |
6 | WOOD, KJ , ISSA, F , HESTER, J , (2016) UNDERSTANDING STEM CELL IMMUNOGENICITY IN THERAPEUTIC APPLICATIONS.TRENDS IN IMMUNOLOGY. VOL. 37. ISSUE 1. P. 5 -16 | 20 | 32% | 3 |
7 | FAIRCHILD, PJ , HORTON, C , LAHIRI, P , SHANMUGARAJAH, K , DAVIES, TJ , (2016) BENEATH THE SWORD OF DAMOCLES: REGENERATIVE MEDICINE AND THE SHADOW OF IMMUNOGENICITY.REGENERATIVE MEDICINE. VOL. 11. ISSUE 8. P. 817 -829 | 21 | 34% | 1 |
8 | TAN, Y , OOI, S , WANG, LS , (2014) IMMUNOGENICITY AND TUMORIGENICITY OF PLURIPOTENT STEM CELLS AND THEIR DERIVATIVES: GENETIC AND EPIGENETIC PERSPECTIVES.CURRENT STEM CELL RESEARCH & THERAPY. VOL. 9. ISSUE 1. P. 63-72 | 24 | 30% | 8 |
9 | PEARL, JI , KEAN, LS , DAVIS, MM , WU, JC , (2012) PLURIPOTENT STEM CELLS: IMMUNE TO THE IMMUNE SYSTEM?.SCIENCE TRANSLATIONAL MEDICINE. VOL. 4. ISSUE 164. P. - | 14 | 52% | 16 |
10 | DE ALMEIDA, PE , RANSOHOFF, JD , NAHID, A , WU, JC , (2013) IMMUNOGENICITY OF PLURIPOTENT STEM CELLS AND THEIR DERIVATIVES.CIRCULATION RESEARCH. VOL. 112. ISSUE 3. P. 549-561 | 26 | 24% | 32 |
Classes with closest relation at Level 1 |